AUROPHARMAAUROPHARMA is symmetrical triangle pattern breakout.
previous trend is good up trend.
I am entry in 1070
stop loss 6% (a stock that FLUCTUATES around 2 % per day)
47.30INR
19.28 BINR
246.38 BINR
281.54 M
About AUROBINDO PHARMA
Sector
CEO
Kambam Nithyananda Reddy
Headquarters
Hyderabad
Website
Employees (FY)
33.41 K
Founded
1986
ISIN
INE406A01037
FIGI
BBG000BMFTS8
Aurobindo Pharma Ltd. engages in the manufacturing of generic pharmaceuticals and active pharmaceutical ingredients. It operates under the following geographical segments: India, USA, Europe, and Rest of the World. Its portfolio includes antibiotics, anti-retrovirals, cardiovascular, central nervous system, gastroenterological, anti-allergies, and anti-diabetics. The company was founded by Penaka Venkata Ramprasad Reddy and Kambam Nithyananda Reddy on December 26, 1986 and is headquartered in Hyderabad, India.
AUROPHARMA - Analysis as COVID news in pictureAs we have seen some Profit booking/selling across the board last week, possible reason could be
- FII getting ready for Holiday
- Covid news
Swing trade above 1106
Investor Buy zone Buy Zone 1072 to 976
Stop loss - Swing trade 1070, Investor 880 on day closing below this levels for minimum t
AUROPHARMA WEEKLY CHARTAUROPHARMA WEEKLY CHART
This chart depicts the future course of the stock, as marked as 0-1--2-3-4-5
This is only an observation & not any suggestion.
simple flag patternAug-13 TO Sep-15 made constant rally, after that stock went in consolidation next 8 years.
we got opportunity year end of dec-2023 with 1D TF channle trend breckout
SL around 5% to 10%
Target Last rally base rally which is 680% return, its long term trade and its not recommendation, this is onl
Aurobindo pharma Auro pharma can give a possible up move might give a good INTRADAY or 2,3 days upside move
Entry - above 1160
Stoploss - 1140
Target - 1180, 1220, 1280++
Note - I'm not sebi registered this is my personal view
AURO Pharma Breakout the Strong Resistance AURO Pharma Breakout the Strong Resistance possible start upside moment in upcoming days possible target 1077-1098-1111-1155
Aurobindo Pharma Monthy Chart Analysis Aurobindo Pharma has given breakout on Monthly Chart we can consider this stock at current market price at 1150 with sl of 1080 for swing trade
SHORT AUROPHARMA for targets 750-760 (CMP: 1110)Short AUROPHARMA for a >30% downside on monthly charts. It has hit and tested multi-year trendline. now ripe for a correction.
NSE:AUROPHARMA
AUROBINDO PHARMAThis stock breakout ATH level TGT will be 1466,2114 and SL will be 962 and this is only for educational purpose only
Auropharma Long callAUROPHARMA broke major resistance level with good volume increase and hovering around support, best buy at 1080 levels with low risk and high return having RRR 1:5.
stoploss 990 and target price of 1450, for long term investment buy.
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of AUROPHARMA is 1089.65 INR — it has decreased by 2.23% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange AUROBINDO PHARMA stocks are traded under the ticker AUROPHARMA.
AUROBINDO PHARMA is going to release the next earnings report on May 30, 2024. Keep track of upcoming events with our Earnings Calendar.
AUROPHARMA stock is 3.29% volatile and has beta coefficient of 0.66. Check out the list of the most volatile stocks — is AUROBINDO PHARMA there?
One year price forecast for AUROBINDO PHARMA has a max estimate of 1400.00 INR and a min estimate of 980.00 INR.
AUROPHARMA earnings for the last quarter are 12.83 INR whereas the estimation was 11.03 INR which accounts for 16.30% surprise. Estimated earnings for the next quarter are 15.39 INR. See more details about AUROBINDO PHARMA earnings.
AUROBINDO PHARMA revenue for the last quarter amounts to 72.19 B INR despite the estimated figure of 68.09 B INR. In the next quarter revenue is expected to reach 73.75 B INR.
Yes, you can track AUROBINDO PHARMA financials in yearly and quarterly reports right on TradingView.
AUROPHARMA stock has fallen by 1.84% compared to the previous week, the month change is a 8.53% rise, over the last year AUROBINDO PHARMA has showed a 84.28% increase.
AUROPHARMA net income for the last quarter is 9.36 B INR, while the quarter before that showed 7.57 B INR of net income which accounts for 23.65% change. Track more AUROBINDO PHARMA financial stats to get the full picture.
Today AUROBINDO PHARMA has the market capitalization of 650.28 B, it has increased by 1.81% over the last week.
AUROBINDO PHARMA dividend yield was 0.58% in 2022, and payout ratio reached 9.12%. The year before the numbers were 1.35% and 19.91% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, AUROPHARMA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade AUROBINDO PHARMA stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 33.41 K employees. See our rating of the largest employees — is AUROBINDO PHARMA on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So AUROBINDO PHARMA technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating AUROBINDO PHARMA stock shows the buy signal. See more of AUROBINDO PHARMA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on AUROBINDO PHARMA future price: according to them, AUROPHARMA price has a max estimate of 1400.00 INR and a min estimate of 980.00 INR. Read a more detailed AUROBINDO PHARMA forecast: see what analysts think of AUROBINDO PHARMA and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. AUROBINDO PHARMA EBITDA is 51.58 B INR, and current EBITDA margin is 15.50%. See more stats in AUROBINDO PHARMA financial statements.